hims compounded semaglutide review Weight Loss Reviews and Effectiveness Hims Tumbles 19% After CEO

Public Plan Spending Context The Globe and Mail reports that public plans spent $794 million on Ozempic in 2024, and if plans cover Mounjaro, it could cost them an estimated $1.97 billion over three years, about $820 million more than the plans currently spend on comparable drugs over a similar period [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]

But in most cases, weve seen that patients exclusively seeking weight loss usually need higher doses of the same drug

Do GLP-1 drugs cause hair loss

Are muscle cramps on Mounjaro dangerous

The GLP-1 component also counteracts the weight gain that insulin causes, creating a more balanced metabolic profile

The company remains locked in an increasingly competitive battle with Eli Lilly in the GLP-1 obesity and diabetes space, with both firms racing to develop next-generation therapies and oral formulations.